Morphosys Ag (MOR.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 10,535 | 10,535 | 10,091 | 8,330 | 6,245 |
| Income taxes - deferred | -1,189 | 168,579 | -76,591 | -75,399 | -3,506 |
| Accounts receivable | 32,047 | -30,090 | 10,533 | -69,620 | 2,667 |
| Accounts payable and accrued liabilities | N/A | -21,093 | -90,816 | 77,505 | 13,202 |
| Other Working Capital | 7,213 | -51,435 | -112,994 | 12,830 | 17,833 |
| Other Operating Activity | -344,444 | -443,201 | -221,668 | 81,623 | -116,580 |
| Operating Cash Flow | $-295,837 | $-366,705 | $-481,445 | $35,270 | $-80,139 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -349 | -1,932 | -3,810 | -4,455 | -3,083 |
| Net Acquisitions | 4,579 | 0 | -1,206,610 | 2,478 | N/A |
| Purchase Of Investment | -3,151,217 | -1,884,857 | -2,191,837 | -1,749,556 | -289,772 |
| Sale Of Investment | 3,146,660 | 2,240,864 | 2,591,976 | 915,582 | 371,880 |
| Purchase Sale Intangibles | -2,523 | -13,296 | -22,346 | -44,881 | -562 |
| Other Investing Activity | 18,224 | 4,225 | 1,618 | 1,211 | 90 |
| Investing Cash Flow | $15,374 | $345,003 | $-831,010 | $-879,623 | $78,552 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 241 | 773 | N/A |
| Debt Issued | N/A | 0 | 0 | 319,946 | 3,714 |
| Debt Repayment | -48,828 | -3,413 | -3,126 | -2,787 | -2,350 |
| Common Stock Issued | 102,696 | 295,421 | 1,291,437 | 80,598 | 0 |
| Other Financing Activity | -10,869 | 19,409 | 34,372 | 508,655 | -1,011 |
| Financing Cash Flow | $42,999 | $311,418 | $1,322,923 | $907,186 | $353 |
| Exchange Rate Effect | -6,387 | -10,613 | 2,985 | 3,398 | 87 |
| Beginning Cash Position | 402,351 | 123,248 | 109,795 | 44,314 | 45,460 |
| End Cash Position | 158,500 | 402,351 | 123,248 | 109,795 | 44,314 |
| Net Cash Flow | $-237,464 | $289,716 | $10,468 | $62,833 | $-1,233 |
| Free Cash Flow | |||||
| Operating Cash Flow | -295,837 | -366,705 | -481,445 | 35,270 | -80,139 |
| Capital Expenditure | -2,873 | -15,229 | -26,156 | -49,337 | -3,666 |
| Free Cash Flow | -298,710 | -381,934 | -507,601 | -14,067 | -83,804 |